
Overview
Dual board-certified in hematology and medical oncology, Dr. Gupta brings over a decade of clinical and research experience and expertise to Atlantic Medical Group. Dr. Gupta works closely with multidisciplinary groups in diagnosis and management of early stage and advanced breast cancers, and cancers of the head and neck area. She closely collaborates with physicians in surgical oncology and radiation oncology to deliver outstanding care to her patients and their family. She also treats benign hematology disorders such as anemia, and other blood abnormalities.Dr. Gupta completed her medical school at one of the best institutions in India and then went on to complete her internal medicine residency and hematology and oncology fellowship at Staten Island University Hospital, Northwell Health. After completing her education, she served as Assistant Professor of Medicine at Northwell Health System in Staten Island. She was also faculty member at State University of New York (SUNY Downstate) during her association with Staten Island Hospital. She subsequently joined the faculty at Weill Cornell Medical Center, New York Presbyterian Hospital, where she continued her commitment to excellent patient care.Dr. Gupta is also an active volunteer for the American Society of Clinical Oncology (ASCO), and continues to participate in various endeavors towards improvement in cancer care at a global level. She is widely published, and has won awards for her research and publications. She continues to actively enroll patients in breast oncology and head and neck oncology and serves as the principal investigator for several clinical trials within Atlantic Health System.Dr. Gupta is also the Associate Program Director of the Hematology and Oncology Fellowship Program at Atlantic Health System, and continues to mentor and train residents and fellows.Fluent in English and Hindi, Dr. Gupta is part of Atlantic Medical Group and a participating provider of the Atlantic Accountable Care Organization.
Dr. Gupta is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Colonic Atresia, Breast Cancer, Paget Disease of the Breast, and Tongue Cancer.
Dr. Gupta is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 100 peer reviewed articles and participating in 3 clinical trials. Dr. Gupta is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Madison Avenue, Carol G Simon Cancer Center 2nd Floor Null, Morristown, NJ 07960
Additional Areas of Focus
Dr. Gupta has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Carol G. Simon Cancer Center
Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Farber is board certified in American Board Of Internal Medicine. Dr. Farber is currently accepting new patients.
Atlantic Medical Group Hematology Oncology
Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration. Dr. Cherry is board certified in American Board Of Internal Medicine. Dr. Cherry is currently accepting new patients.
Atlantic Hematology Oncology
"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer. Dr. Alistar is board certified in American Board Of Internal Medicine. Dr. Alistar is currently accepting new patients.
Atlantic Women's Cancer Associates
Nana Tchabo, MD, FACOG Dr. Nana Tchabo is dual board certified in gynecology-oncology and obstetrics and gynecology, with fellowship training in minimally invasive gynecologic surgery and robotic procedures. A native of Baltimore, MD, Dr. Tchabo is a gynecologic oncologist at Atlantic Health System’s Morristown and Overlook Medical Centers Women’s Cancer Center, part of the Atlantic Medical Group. After graduating from Brown University in 1996 with a bachelor’s degree in neuroscience and a minor in women’s health, Dr. Tchabo attended Brown University School of Medicine for her medical degree, where she was cited for academic excellence. Dr. Tchabo completed her residency in obstetrics and gynecology at Georgetown University in 2004 and pursued additional research training at the National Cancer Institute of the National Institutes of Health in Bethesda, MD, and gynecologic oncology fellowship training at Roswell Park Cancer Institute in Buffalo, NY. Committed to cancer prevention and survivorship, Dr. Tchabo is a principal investigator on many of the gynecologic cancer clinical research trials available at the Carol G. Simon Cancer Center. She also serves as associate residency director for Gynecology at Overlook Medical Center. Dr. Tchabo is an assistant clinical professor at the Sidney Kimmel Medical College of Thomas Jefferson University and is a former assistant clinical professor at Mount Sinai School of Medicine’s department of Obstetrics, Gynecology and Reproductive Science. Dr. Tchabo is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, Ureteroscopy, and Salpingo-Oophorectomy. Dr. Tchabo is board certified in American Board Of Obstetrics And Gynecology. Dr. Tchabo is currently accepting new patients.
Garden State Urology
The relationship between patient and physician is a partnership and the best medicine is practiced as part of a team-based approach with patients, their families and their other physicians. As an experienced fellowship-trained, minimally-invasive urologic oncologic surgeon, my role as your advisor is to provide the most effective medical and surgical techniques for the management of prostate, bladder, kidney, testicular and adrenal cancers. This not only takes into account the disease process, but importantly recognizes the effect on quality-of-life on both patients and caregivers during and following treatment. Education and communication are the hallmarks of ensuring that we are part of a successful team together. Dr. Prasad is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Bladder Cancer, Urothelial Cancer, Ureteroscopy, and Bladder Reconstruction. Dr. Prasad is board certified in American Board Of Urology. Dr. Prasad is currently accepting new patients.
Atlantic Women's Cancer Associates
Since 1999, Dr. Daniel Tobias has been a gynecologic oncologist at Atlantic Health System’s Women’s Cancer Center, diagnosing and treating conditions of the female reproductive system. He is dual board-certified in obstetrics and gynecology and gynecologic oncology, and he is part of Atlantic Medical Group with privileges at both Morristown and Overlook medical centers. He is currently the director of gynecologic oncology for Atlantic Health System.Dr. Tobias attended the University of Missouri-Kansas City School of Medicine for an integrated six-year combined bachelors of arts and medical degree program. He performed his residency at Albert Einstein College of Medicine’s Montefiore Medical Center and his fellowship in gynecologic oncology at Mount Sinai School of Medicine in New York. During his fellowship, Dr. Tobias served as principal investigator of a study initiated by the New York Gynecologic Oncology Group. Keenly interested in research, Dr. Tobias continues to bring clinical trials and research to his patients.As part of an integrated care team, Dr. Tobias treats gynecologic malignancies using a combination of modalities and advanced technologies to spare healthy tissue. His medical career includes many honors, awards, presentations and authored works.Dr. Tobias is affiliated with and involved in several professional societies including the Society of Gynecology Oncologists and the American College of Obstetricians and Gynecologists. He has extensive experience with radical surgery, intraperitoneal chemotherapy and laparoscopic surgery. Dr. Tobias has performed robotic surgery since 2005, helped develop a comprehensive gynecologic oncology robotics program, and trains other physicians to perform robotics surgery. He also participates in resident education. Dr. Tobias is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, Bladder Reconstruction, and Hernia Surgery. Dr. Tobias is board certified in American Board Of Obstetrics And Gynecology. Dr. Tobias is currently accepting new patients.
Frequently Asked Questions about Dr. Shilpi P. Gupta
How do I make an appointment with Dr. Shilpi P. Gupta?
You can book an appointment with Dr. Shilpi P. Gupta by calling their office at 973-971-7960. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Shilpi P. Gupta a top-rated expert for Colonic Atresia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shilpi P. Gupta is classified as an Distinguished expert for Colonic Atresia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Shilpi P. Gupta specialize in?
While Dr. Shilpi P. Gupta is a Hematology, they have specific expertise in Colonic Atresia, Breast Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Shilpi P. Gupta participate in research or clinical trials?
Yes. Dr. Shilpi P. Gupta has published 34 articles and abstracts on conditions like Colonic Atresia. You can view a list of Dr. Shilpi P. Gupta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Shilpi P. Gupta accept my insurance?
Dr. Shilpi P. Gupta accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 973-971-7960 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Gupta isDistinguished. Learn about Breast Cancer.
- Colonic AtresiaDr. Gupta isDistinguished. Learn about Colonic Atresia.
- Paget Disease of the BreastDr. Gupta isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Inflammatory Breast CancerDr. Gupta isAdvanced. Learn about Inflammatory Breast Cancer.
- ThrombocytopeniaDr. Gupta isAdvanced. Learn about Thrombocytopenia.
- Tongue CancerDr. Gupta isAdvanced. Learn about Tongue Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Gupta isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adenoid Cystic CarcinomaDr. Gupta isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Immune ThrombocytopeniaDr. Gupta isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Gupta isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Gupta isExperienced. Learn about Anemia.
- AngiosarcomaDr. Gupta isExperienced. Learn about Angiosarcoma.
- Bone TumorDr. Gupta isExperienced. Learn about Bone Tumor.
- Breast Cancer in MenDr. Gupta isExperienced. Learn about Breast Cancer in Men.
- Cervical CancerDr. Gupta isExperienced. Learn about Cervical Cancer.
- Childhood Acute Myeloid LeukemiaDr. Gupta isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Gupta isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Familial NeutropeniaDr. Gupta isExperienced. Learn about Chronic Familial Neutropenia.
- Chronic Lymphocytic Leukemia (CLL)Dr. Gupta isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. Gupta isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Colorectal CancerDr. Gupta isExperienced. Learn about Colorectal Cancer.
- Essential ThrombocythemiaDr. Gupta isExperienced. Learn about Essential Thrombocythemia.
- Familial Colorectal CancerDr. Gupta isExperienced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Gupta isExperienced. Learn about Familial Pancreatic Cancer.
- Febrile NeutropeniaDr. Gupta isExperienced. Learn about Febrile Neutropenia.
- Gastric LymphomaDr. Gupta isExperienced. Learn about Gastric Lymphoma.
- Gastroesophageal Junction CancerDr. Gupta isExperienced. Learn about Gastroesophageal Junction Cancer.
- GliomaDr. Gupta isExperienced. Learn about Glioma.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Hemangioma Thrombocytopenia SyndromeDr. Gupta isExperienced. Learn about Hemangioma Thrombocytopenia Syndrome.
- HER-2 Positive Breast CancerDr. Gupta isExperienced. Learn about HER-2 Positive Breast Cancer.
- Immune Thrombocytopenic Purpura (ITP)Dr. Gupta isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- Laryngeal CancerDr. Gupta isExperienced. Learn about Laryngeal Cancer.
- Lung CancerDr. Gupta isExperienced. Learn about Lung Cancer.
- Lynch SyndromeDr. Gupta isExperienced. Learn about Lynch Syndrome.
- Malignant Mixed Mullerian TumorDr. Gupta isExperienced. Learn about Malignant Mixed Mullerian Tumor.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Gupta isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Gupta isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Nasopharyngeal CarcinomaDr. Gupta isExperienced. Learn about Nasopharyngeal Carcinoma.
- Non-Hodgkin LymphomaDr. Gupta isExperienced. Learn about Non-Hodgkin Lymphoma.
- Oral Squamous Cell CarcinomaDr. Gupta isExperienced. Learn about Oral Squamous Cell Carcinoma.
- Ovarian CancerDr. Gupta isExperienced. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Gupta isExperienced. Learn about Ovarian Carcinosarcoma.
- Pancreatic CancerDr. Gupta isExperienced. Learn about Pancreatic Cancer.
- PeriodontitisDr. Gupta isExperienced. Learn about Periodontitis.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Pleuropulmonary BlastomaDr. Gupta isExperienced. Learn about Pleuropulmonary Blastoma.
- Polycythemia VeraDr. Gupta isExperienced. Learn about Polycythemia Vera.
- Richter SyndromeDr. Gupta isExperienced. Learn about Richter Syndrome.
- Salivary Gland TumorsDr. Gupta isExperienced. Learn about Salivary Gland Tumors.
- Schnitzler SyndromeDr. Gupta isExperienced. Learn about Schnitzler Syndrome.
- Sertoli-Leydig Cell TumorDr. Gupta isExperienced. Learn about Sertoli-Leydig Cell Tumor.
- Severe Congenital NeutropeniaDr. Gupta isExperienced. Learn about Severe Congenital Neutropenia.
- Sickle Cell DiseaseDr. Gupta isExperienced. Learn about Sickle Cell Disease.
- Smoldering Multiple MyelomaDr. Gupta isExperienced. Learn about Smoldering Multiple Myeloma.
- Testicular Yolk Sac TumorDr. Gupta isExperienced. Learn about Testicular Yolk Sac Tumor.
- Throat CancerDr. Gupta isExperienced. Learn about Throat Cancer.
- Thymic Epithelial TumorDr. Gupta isExperienced. Learn about Thymic Epithelial Tumor.
- Virilizing Ovarian TumorDr. Gupta isExperienced. Learn about Virilizing Ovarian Tumor.





